newsfilter
← Latest News
GlobeNewswire·

Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Added important patents further protecting the company's therapeutic delivery technologies Added strong biotherapeutics capabilities to management team and board of directors Implemented cost-cutting measures expected to result in approximately $14